Tests:Infectious Mononucleosis, Plasma: Difference between revisions

From Taranaki Lab Manual
Tests:Infectious Mononucleosis, Plasma
Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
[[Category:Tests]]  
[[Category:Tests]]  


[[Category:Microbiology]]   
[[Category:Haematology]]   
{| class="wikitable"
{| class="wikitable"
! colspan="2" |
! colspan="2" |

Revision as of 16:39, 3 July 2025

Overview

Department Haematology  
Test Code IM
Synonyms Monospot  

Paul Bunnell  

Glandular fever  

IM

Base Lab Availability Monday - Sunday, testing routinely available out of hours
Hawera Lab Availability Monday - Friday 8 am - 5pm
Turnaround Time 1-5 hrs  
Stability – Add test 24 hrs at room temp, 3 days at 4 degrees Celsius.

Specimen Requirements

Specimen Plasma
Specimen Transportation
Preferred 6mL Plain Red-Top
Acceptable 4mL EDTA Purple-Top , or Li-Hep Green-Top
Unacceptable
Paediatric Requirements   0.5 mL Plain Red-Top, 500 μL EDTA Microtainer , or 600 μL Li-Hep Microtainer    

Aliquot Requirements

Sample
Preferred Volume
Minimum Volume
Aliquot Transportation

Clinical Information

Reference Intervals Positive test suggests the diagnosis of glandular fever in the context of appropriate symptoms and blood film changes such as reactive lymphocytosis.    
Test Method Clearview IM rapid immunoassay kit for detection of EBV IgM Heterophile Antibody.  
Advanced Notice
Patient Preparation

Comments

This test screens for the presence of heterophile antibodies.  EBV serology is the preferred test in cases of suspected infectious mononucleosis due to the inferior sensitivity of the monospot test.  

The monospot test will not be performed on children <6yrs due to the poor sensitivity in this age group.  

Any sample with a negative monospot test result will be referred for EBV serology.  

 

Limitations of the monospot test:  

During the first week of disease 30-40% of patients will produce a false negative result. Suggest repeat EBV serology if symptoms persist.  

50% of children <6 years of age and 10-20% of adults will not produce heterophile IM antibodies.    

False positive results may be seen in cases of CMV, malaria, toxoplasmosis and some autoimmune diseases.